| Symbol | DTCFF |
|---|---|
| Name | DEFENCE THERAPEUTICS INC |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | H4S1Z9 Canada QC 7171 rue Frederick-Banting |
| Telephone | +1 5149472272 |
| Fax | — |
| — | |
| Website | https://defencetherapeutics.com/ |
| Incorporation | CA |
| Incorporated On | 2020 |
| Employees | — |
| Fiscal Year | 6/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Crowe MacKay LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Canadian Securities Exchange |
| CIK | — |
| Description | Defence Therapeutics Inc. is a biotechnology company engaged in the business of research and development, focusing on enhancing delivery of tumor and infectious disease-specific therapeutics using its proprietary Accum® platform. The principal business carried on is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. Additional info from OTC: |
No news found.